Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
Wenzhan Yang, Sugandha Saboo, Liping Zhou, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 2, pp. 103865-103865
Closed Access | Times Cited: 9

Showing 9 citing articles:

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
Dana E. Moseson, Tran Trong Bien, Bharathi Karunakaran, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100259-100259
Open Access | Times Cited: 26
Prodrug Approach as a Strategy to Enhance Drug Permeability
Mariana Moraes Dionysio de Souza, Ana Luísa Rodriguez Gini, Jhonnathan Alves Moura, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 297-297
Open Access
From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs
Lynne S. Taylor, George Zografi
Molecular Pharmaceutics (2025)
Closed Access
Use of Poly(vinyl alcohol) in Spray-Dried Dispersions: Enhancing Solubility and Stability of Proteolysis Targeting Chimeras
Lena Mareczek, Lena Karin Mueller, Laura Halstenberg, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 3
Unraveling the complexity of amorphous solid as direct ingredient for conventional oral solid dosage form: The story of Elagolix Sodium
Raimundo Ho, Richard S. Hong, Joseph Kalkowski, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124656-124656
Closed Access | Times Cited: 1
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Proteolysis Targeting Chimeras (PROTACs): An Innovative Strategy for Targeted Protein Degradation and Disease Treatment
Jun Xia, James K.S. Norris, M. Mackinnon, et al.
International Journal of Drug Discovery and Pharmacology (2024), pp. 100015-100015
Closed Access
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs
Andrea Venturi, Stefano Di Bona, Jenny Desantis, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
Page 1

Scroll to top